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Sulfatasens (HSPGs) are synthesised and modiﬁed in the Golgi before they are presented
at the cell surface. Modiﬁcations include the addition of sulfate groups at speciﬁc positions on sugar residues
along the heparan sulfate (HS) chain which results in a structural heterogeneity that underpins the ability of
HSPGs to bind with high afﬁnity to many different proteins, including growth factors and their receptors.
Sulf1 codes for a 6-0-endosulfatase that is present and active extracellularly, providing a further mechanism
to generate structural diversity through the post-synthetic remodelling of HS. Here we use Xenopus embryos
to demonstrate in vivo that Xtsulf1 plays an important role in modulating cell signaling during development.
We show that while XtSulf1 can enhance the axis-inducing activity of Wnt11, XtSulf1 acts during
embryogenesis to restrict BMP and FGF signaling.
© 2008 Elsevier Inc. All rights reserved.Introduction
Heparan sulfate proteoglycans (HSPGs) are present on the cell
surface and in the extracellular matrix in all metazoans. HSPGs are
synthesised and subsequently modiﬁed in the Golgi by the addition of
sulfate groups to speciﬁc sugar residues along the heparan sulfate (HS)
chain (for review see Turnbull et al., 2001). There are speciﬁc sulfo-
transferase enzymes that add sulfate groups to the 2-O position of
iduronic acid, and to the N-, 3-O, and 6-O positions of glucosamine;
however these enzymes do not modify all the available substrate and
this results in a rich structural diversity of HS chains. The structural
variation of HS likely underpins the ability of HSPGs to bind with high
afﬁnity to many different proteins, including growth factors and their
receptors.
Drosophila mutants including sugarless (Hacker et al., 1997), sulfa-
teless (Lin et al., 1999), tout-velu (Bellaiche et al., 1998), slalom (Luders
et al., 2003), and fringe-connection (Selva et al., 2001) all code for
enzymes or transporters involved in HS biosynthesis and all of these
mutants are defective inWg, Dpp, FGF and/or Hh signaling, supporting
the notion that HSPGs play an essential role in developmental cell
signaling. The impact of HSPGs on cell signaling is best described for
the FGF signal transduction pathway (Ornitz, 2000). FGF proteins act
through high afﬁnity receptor tyrosine kinases (RTKs) where ligand
binding promotes receptor dimerisation and tyrosine phosphorylation
initiates a signal transduction cascade that stimulates Ras and leads tol rights reserved.the phosphorylation of ERK (reviewed by Fantl et al., 1993). Heparan
sulfate is considered a low afﬁnity co-receptor for the FGF ligand,
forming a ternary complex with FGF and the FGF receptor that
facilitates receptor dimerisation. Importantly, it has been found that
this interaction relies on speciﬁc sulfate groups within the HS chain.
Biochemical and structural studies have shown that 6-O-sulfation of
HS chains is required to promote the activity of bFGF (Guimond and
Turnbull, 1999; Pye et al., 1998; Schlessinger et al., 2000). Other
secretedmolecules such as BMPs,Wnts and Noggin are known to bind
HSPGs (Paine-Saunders et al., 2002; Paine-Saunders et al., 2000; Tao et
al., 2005) and there is no reason to think that their associationwould be
any less speciﬁc.
Another family of enzymes, encoded by Sulf1 and Sulf2, are 6-O-
endosulfatases that provide a further mechanism to generate struc-
tural heterogeneity along the HS chain by post-synthetically modify-
ing HS structure. An intriguing feature of these enzymes is that they
are present and active extracellularly (Ai et al., 2006). Furthermore,
the Sulf enzymes have been shown to have a highly speciﬁc bio-
chemical activity as 6-O-endosulfatases: they act only on a subset of
trisulfated disaccharides within highly sulfated domains of heparan
sulfate by removing sulfate groups from the 6-O position of N-ace-
tylglucosamine (Ai et al., 2006; Ai et al., 2003; Viviano et al., 2004).
Genes coding for Sulf enzymes have been identiﬁed in quail (Ai et
al., 2006; Dhoot et al., 2001), mouse and human (Morimoto-Tomita et
al., 2002) and studies in tissue culture cells and Xenopus explants have
shown that these enzymes inhibit FGF (Lai et al., 2003; Wang et al.,
2004), EGF (Lai et al., 2003), and HGF (Lai et al., 2004a) signaling and
promote Wnt signaling (Ai et al., 2003; Dhoot et al., 2001). Sulf1 can
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al., 2004). Here we use the amphibian Xenopus tropicalis to demons-
trate that Xtsulf1 expression is highly regulated during development
and plays an important role in modulating cell signaling in vivo. We
ﬁnd that Sulf1 can enhanceWnt11 activity, and that XtSulf1 is required
to restrict FGF signals in embryos. We also show for the ﬁrst time that
Sulf1 is an endogenous inhibitor of BMP signaling.
Materials and methods
mRNA injections
Xtsulf1was identiﬁed by homology to Qsulf1 (Dhoot et al., 2001) as two overlapping
X. tropicalis ESTs: Tegg051c23 and Tegg085l18 (Wellcome Trust Sanger Institute and
Wellcome Trust/Cancer Research UK Institute X. tropicalis EST Project (Gilchrist et al.,
2004); the coding region was ampliﬁed and cloned into pCS2+. All mRNAs for
microinjection were synthesised using SP6 Megascript kit (Ambion) and were derived
from the following plasmids: CS2-XtSulf1 (Genbank EF409382), CS2-XtSulf1-eGFP,
pSP64T-eFGFi (Isaacs et al., 1994), CS2-iFGF-R1 (Pownall et al., 2003), pSP64T-BMP4
(Dale et al., 1992), CS2-Alk3 (BMPR1 Q233D) (Hansen et al., 1997), pCS107-XtWnt11
(EST TNeu076g04) (Gilchrist et al., 2004), pCS2-Wnt11HA (Tao et al., 2005),
pCS2LRP6ΔCmyc (Tamai et al., 2000), pCS2-BMP4-HA (Haramoto et al., 2004), pCS2-
BMPR-GST (BMPR1 cloned in frame into the CS2-GST plasmid).
Expression analyses
Whole mount in situ hybridisation was carried out on Xenopus embryos using a
modiﬁed Harland protocol (Tindall et al., 2005). 50 mm sections were cut from
specimens subsequent to ISH using a Leica Vibratome. The XtSulf1 probe is a 700 bp
EcoR1 subclone into pBluescript-KS. X. laevis probes were generated as previously
described for pSP73-Xbra (Smith et al., 1991), pSP73-XmyoD (Hopwood et al., 1989),
Otx2 (Pannese et al., 2000) and Pax6 (Hirsch and Harris, 1997). ESTs coding for Szl
(IMAGE:4057152), Msx1 (IMAGE:6864746), Chordin (IMAGE:516617), and Xnr3
(IMAGE: 7297499) were identiﬁed and used to generate probes. X. tropicalis probes
Xtcdx4 (Reece-Hoyes et al., 2002), XtmyoD (Fisher et al., 2003) were used as previously
described. ESTs coding for XtWnt11 (TNeu076g04), bowline (TNeu005e10) and
thylacine (TGas088i24) were identiﬁed and used to generate probes. XtSulf1-eGFP
was visualised in excised animal caps by confocal microscopy.
Heparan sulfate extraction and analysis
150 X. laevis embryos were homogenized and extracted in Trizol reagent. The
aqueous phase was applied to a DEAE column; HS was eluted with 2 M NaCl, and
desalted on a D10 column. Disaccharide composition was determined by strong anion
exchange HPLC as described previously (Brickman et al., 1998). Brieﬂy, puriﬁed HS
samples were treated with a mixture of recombinant heparinases I, II and III (2.5 mU
each; Ibex Ltd, Canada) in 100 mM sodium acetate buffer, pH 7.0, containing 0.1 mM
calcium acetate. A Pro-Pac PA1 SAX column (Dionex)was equilibrated and disaccharides
were eluted with a linear gradient of sodium chloride (0–1 M over 45 min).The eluant
was monitored in-line for UV absorbance at 232 nm. Peaks were identiﬁed by reference
to authentic standards separated under the same run conditions in sequential runs.
Anti-sense morpholino oligos
Morpholino oligonucleotides directed against the splice junction of exon2/3 were
heated at 55 °C for 5 min immediately before injection into both blastomeres of X.
tropicalis embryos at the two-cell stage (15 ng total). X. tropicalis embryos were
generated and cultured according to protocols on the Harlandwebsite (http://tropicalis.
berkeley.edu/home/). The control MO was provided by GeneTools. AMO3 and AMO4




Embryos were ﬁxed in 4% paraformaldehyde, stained in 10% borax carmine,
destained in acid alcohol, and embedded in parafﬁn. Sections were counterstained with
picro-blue-black (97.5% saturated picric acid, 0.25% naphthalene blue black).
Animal cap assays
Embryos were injected at the 2-cell stage with mRNA coding for BMP4 or ALK4
alone or in combination with XtSulf1. Animal cap explants were isolated at stage 8,
cultured until stage 10, frozen and processed for Western blot analysis. In other
experiments, embryos were injected at the 2-cell stagewith mRNA coding for XtSulf1 or
iFGFR1 or XtSulf1 together with iFGFR1; animal cap explants were isolated at stage 8
and exposed to FGF4 protein or the dimerising drug AP20187 (Pownall et al 2003) and
cultured until stage 10, frozen and processed for Western blot analysis.Western blots
Embryos or explants were homogenized in PhosphoSafe extraction buffer (Merck),
run on a 7.5% SDS-PAGE gel and transferred onto PVDFmembrane. Anti-dpERK (1:4000;
Sigma), anti-pSMAD 1/5/8 (1:500; Cell Signaling), and anti-GAPDH (1:106, HyTest Ltd)
were detected using enhanced chemiluminescence (ECL) (Roche).
Immunoprecipitations and GST pull-downs
Embryos were injected with synthetic mRNA coding for LRPΔC-Myc (Tamai et al.,
2000), Wnt11-HA (Tao et al., 2005), and/or Xtsulf1. Gastrula-stage embryos were lysed
in 137mMNaCl, 20mM Tris–HCl pH8.0, 2 mM EDTA,1% NP-40, with protease inhibitors
(Roche) and incubated with anti-HA (1:1000, Covance). After binding to ProteinA beads
(KPL) proteins were separated by SDS-PAGE and immunoblotted using anti-Myc 9B11
(1:3000, Cell Signaling). GST pull-downs were carried out as in Yaklichkin et al. (2007),
brieﬂy, embryos injected into one cell at the 2-cell stage with 1 ng of mRNA coding for
BMPR-GST with or without XtSulf1, and into the other cell with 4 ng of mRNA coding for
BMP-HA. Embryos were collected at early gastrula stages and homogenized in ice-cold
interaction buffer (40 mM HEPES (pH7.5), 2.5 mM MgCl2, 100 mM KCl, 0.2 mM EDTA,
1 mM DTT, 1%NP40, protease inhibitor mixture (Roche)). After a clearing spin, the
supernatant was incubated with the glutathione-agarose beads for 30 min with gentle
mixing. The supernatant was removed following a short spin and the beads were
washed with ice-cold interaction buffer. Bound proteins were eluted by the addition of
SDS-PAGE loading buffer and subjected to Western analysis using antibodies against
GST and HA epitopes.
Results
XtSulf1 expression is highly regulated during development
In order to investigate the role of the Sulf1 enzyme during develop-
ment, we have identiﬁed X. tropicalis Sulf1 (XtSulf1) as two overlapping
cDNAs in the EST database (Gilchrist et al., 2004) and analysed its
expression usingwholemount in situ hybridisation (Fig.1). The zygotic
expression of XtSulf1 initiates during gastrula stages and by late
gastrula (stage 13) (Nieuwkoop and Faber, 1967) there is strong
expression in the posterior paraxial mesoderm (Fig. 1A). During late
neurula stages (Fig. 1B), XtSulf1 is expressed in the pre-segmental
mesoderm, the somites, the ﬂoorplate of the neural tube and the
ventral part of the hindbrain. During early tailbud stages (Fig. 1C),
XtSulf1 continues to be expressed in the posterior mesoderm and
somites, ventral parts of the hindbrain and the ﬂoorplate, and is now
detected in the pronephros (arrow) and neural crest cells (arrowhead).
In later tailbud stages (Fig. 1D), XtSulf1 is expressed in the posterior
mesoderm just rostral to the tailbud and in the ﬁn, somites, ﬂoorplate,
pericardium, and branchial arches. Expression is also found in the lens
and the ciliarymarginal zone of the eye and the ventricular zone of the
midbrain (Fig. 1E; arrow indicates CMZ and arrowhead indicates lens).
Fig. 1F is a section through the embryo shown in Fig. 1C and shows the
expression of XtSulf1 in the ﬂoorplate (arrow) and pronephros
(arrowhead). XtSulf1 is no longer expressed in the pronephros at
later tailbud stages (Fig.1D), while there is continued expression in the
ﬂoorplate and somites (Figs. 1D and G). This dynamic expression
pattern shows that XtSulf1 is highly regulated during development and
expressed in regions of the embryo known to be involved in inductive
interactions, cell proliferation or cell migration. This supports the
notion that XtSulf1 could play a role in regulating the multiple cell
signaling events that regulate these processes during embryonic
development.
XtSulf1 over-expression disrupts development
In order to investigate the biological activity of the XtSulf1 enzyme,
we injected synthetic mRNA coding for XtSulf1 into 4-cell stage
embryos. The results from these over-expression studies are shown in
Figs. 2A–G. When XtSulf1mRNA is targeted to the animal hemisphere
(presumptive ectoderm), the resulting embryo (Figs. 2C and D) shows
an expansion of the cement gland and a disruption of eye develop-
ment that includes a reduction or displacement of retina pigment
epithelium, increase in neural retina, and loss of the lens (74%;
N=102). FGF2 has been shown to drive proliferating retinal stem cells
Fig. 1. Zygotic expression of XtSulf1 analysed by whole mount in situ hybridisation. (A) Stage 13 embryo shows XtSulf1 expression in the posterior paraxial mesoderm (dorsal view;
anterior to the left). (B) Stage 20 embryo shows XtSulf1 expression in the pre-segmented posterior mesoderm, the somites, and the ventral part of the hind brain and the ﬂoorplate of
the neural tube (lateral view; anterior to the left). (C) Stage 26 embryo shows expression in the posterior mesoderm, the somites, the hindbrain, the ﬂoorplate of the neural tube, the
retina of the eye, some neural crest (arrowhead), and the pronephros (arrow). (D) At later tailbud stages, XtSulf1 is expressed in the mesoderm of the tailbud, the somites, the
hindbrain, the neural crest (arrowhead), the ﬂoorplate of the neural tube, the ﬁn, the pericardium, the lens, the ciliary marginal zone (CMZ) of the retina, and in the ﬁrst branchial
arch. (E) Vibratome section through D showing expression of XtSulf1 in the ventricular part of the midbrain, the lens (arrowhead) and CMZ of the eye (arrow). (F) Vibratome section
through C showing the expression in the pronephros (arrowhead) and the ﬂoorplate (arrow). (G) Vibratome section of D showing the expression of XtSulf1 in the somites and
ﬂoorplate.
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known to inhibit FGF (Lai et al., 2004b; Wang et al., 2004), the
hypertrophy seen in Fig. 2D may reﬂect an inhibition of FGF regulated
exit from the cell cycle. The vast increase in cement gland size is
characteristic of a dorsalised phenotype that can result from the per-
turbation of many different signaling pathways, including the
inhibition of BMP signaling (Smith et al., 1993; Suzuki et al., 1994).
When XtSulf1mRNA is injected into the ventral two blastomeres at
the 4-cell stage (Figs. 2E and F), this results in bifurcation of the
developing heart (42%; N=12). This is an unexpected ﬁnding as the
heart is derived from more dorsal regions and suggests that XtSulf1
over-expressionmay impair themigration and/or fusion of the cardiac
mesoderm (reviewed by Mohun et al., 2003). Injection of XtSulf1
mRNA into the marginal zone (presumptive mesoderm) (Fig. 2G)
results in a major disruption of gastrulation movements such that the
blastopore fails to close (68%; N=48); this effect is not seen when the
same amount of mRNA coding for LacZ is injected (data not shown).
These embryos also show enlarged cement glands and disruption or
failure of eye formation. Overall the phenotype of these embryos is
very similar to those in which FGF signaling has been inhibited with a
dominant negative receptor (Amaya et al., 1991; Hongo et al., 1999;
Isaacs et al., 1994).
XtSulf1 localises to the cell membrane and re-structures HSPGs
The molecular mechanism by which XtSulf1 impacts on develop-
mental signals can be deduced from the large body of biochemistry
that has been done on its quail orthologue, QSulf1. QSulf1 has been
shown to localise and act extracellularly to speciﬁcally modify the
sulfation pattern of cell surface HSPGs. By this mechanism, Sulf1
enzymes can alter the afﬁnity of HSPGs for proteins, including ligands
and their receptors, resulting in the enhancement or inhibition of cell
signaling. We show here that XtSulf1 has the same sub-cellular
localisation and biochemical activity as QSulf1. Injection of mRNA
coding for an XtSulf1-eGFP fusion protein shows that the tagged
XtSulf1 protein localises to the cellmembrane (Fig. 2H), consistentwith
previous studies that have shown that this family of endosulfatases is
localised and acts extracellularly (Ai et al., 2006; Ai et al., 2003; Dhoot
et al., 2001). The enzymatic activity of the Sulf1 protein is known to besubstrate-speciﬁc (Ai et al., 2003) and we show in Fig. 2J that over-
expressing XtSulf1 in Xenopus embryos results in a speciﬁc loss of
known 6-O-sulfated Sulf1 substrates, in particular trisulfated dis-
accharide units (IdoA2S-GlcNS6S) within heparan sulfate chains. HS
was extracted at the gastrula stage from control (Fig. 2I) and embryos
over-expressing XtSulf1 (Fig. 2J), depolymerised into disaccharide
products, and separated by SAX-HPLC. Analysis of the disulfated and
trisulfated disaccharides shows that 6-O-sulfation is selectively
reduced in the XtSulf1 injected embryos. The levels of the 6-O-
sulfate-containing disaccharides, both trisulfated (ΔUA2S-GlcNS6S)
and disulfated (ΔUA-GlcNS6S), were signiﬁcantly reduced (to ∼4% and
30% of control levels respectively in comparison to the 2-O-sulfated
disaccharide ΔUA2S-GlcNS). These data indicate that the trisulfated
disaccharide is more susceptible to XtSulf1 action than the disulfated
disaccharide, consistent with previous in vitro reports (Ai et al., 2003;
Viviano et al., 2004).
XtSulf1 is required for normal axis development
In order to determinewhether zygotic XtSulf1 is essential for normal
development we carried out gene knock-down using anti-sense mor-
pholino oligos (AMOs) that inhibit the splicing of exons 2 and 3. Efﬁcient
knock-down by two different AMOs was validated using primer
sequences found within exon 2 and exon 3 such that rtPCR ampliﬁes a
500 bp fragment from the correctly spliced mRNA, while incorrectly
spliced RNA does not permit ampliﬁcation of any product under these
PCR conditions (Fig. 2K). The codon for the cysteine essential for the
catalytic activity of Sulf1 (Ai et al., 2003; Dhoot et al., 2001) is present in
exon 3 so that failure to correctly splice this exonwill result in the loss of
XtSulf1 activity. An embryo injected with 15 ng of a control morpholino
oligo is shown in Fig. 2L, while the phenotypes generated by knock-
down of XtSulf1with 15 ng of AMO3 are shown in Figs. 2M and N. Both
AMO3 and AMO4 (data not shown) give a consistent phenotype
characterised by shortened axes and loss of anterior structures. The
eyes in embryos lacking XtSulf1 are malformed and lack retina pigment
epithelium (RPE) and have no lens (Fig. 2P). Co-injection of XtSulf1
mRNA with the AMO results in the rescue of anterior structures
(Supplementary data Fig. 1). Further histology of knock-down embryos
reveals defective brain vesicles, severely reduced retina and no lens,
Fig. 2. XtSulf1 over-expression and knock-downphenotypes. (A) Control X. laevis embryo and (B) a section through forebrain, eyes, pharynx and cement gland of a control embryo. (C)
Sibling embryo injected into the animal hemisphere with 4 ng mRNA coding for XtSulf1. (D) Section though C showing enlarged cement gland and malformed eye. (E) Sibling embryo
injected into the two ventral blastomeres at the 4-cell stage with 4 ng mRNA coding for XtSulf1. (F) Section though E showing a bifurcated heart. (G) Sibling embryo injected into the
marginal zone with 4 ng mRNA coding for XtSulf1 showing severe gastrulation defects, enlarged cement gland, and malformed eyes. (H) Extracellular localisation of XtSulf1-eGFP in
stage 9 animal cap explants. (I) Normal SAX-HPLC proﬁle of sulfation motifs found in heparan sulfate (HS) disaccharide subunits extracted from X. laevis embryos. (J) The same
analysis on HS extracted from embryos over-expressing XtSulf1 shows a dramatic decrease in the trisulfated disaccharide (NS2S6S). (K) Cartoon depicting the targeting of splice-
blocking anti-sense morpholino oligos to the exon 2/3 splice junction; AMO3 targets the sequence around the splice donor, while AMO4 targets the splice acceptor. Primers are
designed for rtPCR across the two exons such that a product will only be ampliﬁed from correctly processed mRNA. rtPCR on RNA extracted from early neurula embryos either
uninjected or injected with a control morpholino oligo (CMO) ampliﬁes a 500 bp cDNA fragment representing sequences spanning exon 2 and exon 3. The disruption of splicing by
either AMO3 or AMO4 gives no PCR product with the same primers and conditions indicating that XtSulf1 is efﬁciently knocked down in these embryos. (L) Embryo injected with
15 ng of control morpholino oligo. (M, N) Embryos injected at the 2-cell stage into each blastomere with a total of 15 ng of XtSulf1 AMO4. (O) Section through L showing normal
structure of the forebrain, pharynx, eyes (arrow head), and cement gland (arrow). (P) Section through L showing the poorly differentiated and disrupted forebrain, eyes (arrow head),
and cement gland (arrow).
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(Supplementary data Fig. 2). Anterior truncations similar to those found
in XtSulf1 knock-down embryos have been described in embryos where
FGF (Pownall et al., 1996) or BMP (Hartley et al., 2001) signaling is over-
activated during gastrula stages. In contrast, the embryos over-
expressing XtSulf1 have complementary phenotypes consistent with
the inhibition of FGF or BMP signaling (see above). As Sulf1 enzymes are
known to affect multiple signaling pathways in tissue culture, we
analysed the ability of XtSulf1 to inﬂuence Wnt, BMP and FGF signaling
during Xenopus development.
XtSulf1 can enhance the axes-inducing activity of Wnt-11
There is some evidence that Sulf1 can promote Wnt signaling: myo-
blasts expressing a TCF responsive luciferase reporter, and co-culturedwith Wnt1 expressing cells, show enhanced reporter activity when
expressing QSulf1 (Ai et al., 2003; Dhoot et al., 2001). Maternal XtWnt11
and XtSulf1 transcripts are co-expressed in the oocyte (not shown) and
cleavage stage embryos (Figs. 3A–F). Figs. 3A, C and E show XtWnt11
expression in 2-cell, 4-cell, and 32-cell embryos as viewed vegetally;
Figs. 3B, D and F show the expression of XtSulf1 in sibling embryos. Both
XtWnt11 and XtSulf1 are expressed in the germ plasmwhich is visible as
punctuate granules accumulating at the cleavage furrows, as well as
more generally in the vegetal hemisphere. Given the co-expression of
XtSulf1 and XtWnt11 we investigated the possibility that they play a
role in a common pathway. Wnt11 is essential for dorsal development
and its ability to activate canonical Wnt signaling relies on the presence
of HSPGs (Tao et al., 2005). We therefore tested whether XtSulf1 could
promote the activity of XtWnt11 in the early amphibian embryo. Fig. 3G
shows the number of double axes (DA, hatched orange/dark orange)
Fig. 3. XtSulf1 enhances the axis-duplicating activity of Wnt11. (A–F) Whole mount in situ hybridisation shows that maternal expression of XtSulf1 co-localises with maternal Wnt11
in cleavage stage embryos (A, C, E, Wnt11; B, D, F, XtSulf1; all vegetal view). (G) Graph quantifying the frequency of double axes formed in embryos when increasing amounts XtSulf1
mRNA is co-injected with 600 pg of Wnt11 mRNA into a single ventral blastomere at the 4-cell stage (OB = open blastopore, DA = double axis, DH = double head). (H) Uninjected
control X. laevis embryo. (I) Embryo injected with 600 pg of mRNA coding for XtWnt-11 into one ventral blastomere at the 4-cell stage. (J) Embryo injected with 600 pg of mRNA
coding for XtSulf1 into one ventral blastomere at the 4-cell stage. (K–M) Embryos co-injected with 600 pg of XtWnt-11 and 600 pg XtSulf1 into one ventral blastomere at the 4-cell
stage show duplicated axes. (N–P) Embryos co-injected with 600 pg of XtWnt-11 and 4 ng of XtSulf1 into one ventral blastomere at the 4-cell stage show duplicated heads and
gastrulation defects. (Q) Section through a control embryo. (R) Section though an embryo shown in K showing duplicated notochord (arrows) and neural tissue. (S–U) In situ
hybridisation showing the expression of chordin in a control stage 10 embryo (S), or embryos co-injected with 600 pg of XtWnt-11 and 600 pg XtSulf1 into one ventral blastomere at
the 4-cell stage (T, U) showing ectopic expression of chordin in the ventral marginal zone (arrows). (V–X) In situ hybridisation showing the expression of Xnr3 in a control stage 10
embryo (V), or embryos co-injected with 600 pg of XtWnt-11 and 600 pg XtSulf1 into one ventral blastomere at the 4-cell stage (W, X) showing ectopic expression of Xnr3 in the
ventral marginal zone (arrows). (Y) Co-immunoprecipitation of Wnt11-HA with LRP6-myc is enhanced when XtSulf1 is also expressed in Xenopus embryos.
440 S.D. Freeman et al. / Developmental Biology 320 (2008) 436–445formed in response to increasing amounts of XtSulf1mRNA co-injected
with Wnt11. Uninjected embryos or embryos injected into one ventral
blastomere at the 4-cell stage with 600 pg of mRNA coding for either
XtWnt11 or XtSulf1 are indistinguishable (Figs. 3H–J). However, when
XtWnt11 and XtSulf1 are co-injected into one ventral blastomere at the4-cell stage (Figs. 3K–M) there is a high percentage (40–70%) of
duplicated axes. The number of secondary axes increases as the amount
of XtSulf1mRNA injected increases (Fig. 3G), and notably, some of these
duplication include head structures (Figs. 3N–P). Histological sections
reveal duplicated notochords (an example is shown in Fig. 3R) in the
441S.D. Freeman et al. / Developmental Biology 320 (2008) 436–445embryos shown in Figs. 3K–M. Axes duplication suggests that a
secondary organiser is being induced by the co-expression of XtSulf1
and Wnt11. Analysis of organiser gene expression at gastrula stages
shows that embryos co-injected with XtSulf1 and XtWnt11 express
ectopic Chordin (Figs. 3S–U) and Xnr3 (Figs. 3V–X) in the injected ventral
marginal zone.
As XtSulf1 acts extracellularly, the mechanism by which it inﬂuen-
ces Wnt signaling is likely to be at the level of receptor–ligand inter-
action. Induction of a secondary axis by canonical Wnt signaling
requires ligand binding to the LDL receptor related protein LRP5/6
(Tamai et al., 2000; Kofron et al., 2007). We therefore investigated if
XtSulf1 can inﬂuence the association of Wnt11 and LRP6. We ﬁnd
that co-immunoprecipitation of Myc-tagged LRP6 and HA-tagged
Wnt11 increases in embryos over-expressing XtSulf1 (Fig. 3Y) which
suggests that there is an enhanced interaction of this signaling com-
plex in the presence of XtSulf1. It is also notable that the amount of
Wnt11 and LRP6 present in the lysate decreases when they are co-
expressed (Fig. 3Y); this likely reﬂects the uptake and processing of the
ligand–receptor complex. However, the lysate levels of receptor and
ligand are equal between the lanes expressing Wnt and LRP6 in the
presence or absence of XtSulf1, while the amount of LRP6 pulled down
byWnt11 is increased in the sample expressing XtSulf1. This increasedFig. 4. XtSulf1 inhibits BMP signaling in Xenopus embryos. (A–I) show the effects of over-expre
BMP4 activity. (A) Western blotting to detect phospho-SMAD1/5/8 in stage 10 animal caps in
expression of XtSulf1 results in the inhibition of BMP4 activation of pSMAD1, while it has no e
to pull down an HA-tagged BMP4 in whole embryos. In the presence of XtSulf1 less BMP4 is
results in low levels of NCAM expression as analysed by RNAase protection analysis. In situ
regulated in embryos over-expressing XtSulf1. Panels D and G are uninjected stage 10 control
XtSulf1mRNA, and panels F and I have been injected into all blastomeres at the 4-cell stage w
X. tropicalis embryos at stage 14. Embryos where XtSulf1 has been knocked down show eleva
situ hybridisation of X. tropicalis embryos at stage 16 shows that embryos unilaterally injecte
and L) and Pax6 (M–P) which are known to be negatively regulated by BMP4 signaling.association of LRP6 and Wnt11 in embryos over-expressing XtSulf1 is
consistent with the increased axes-inducing activity of Wnt11 mRNA
when co-injected with XtSulf1. Furthermore, the co-localisation of
maternal XtSulf1 and XtWnt11 transcripts points to the possibility for
an endogenous role where XtSulf1 modiﬁes HSPGs to facilitate dorsal
axis speciﬁcation by Wnt11. However, as this process is known to be
maternally driven, maternal depletion of XtSulf1 will be needed to
determine whether these interactions are essential for axis formation.
XtSulf1 inhibits BMP signaling during Xenopus development
The regulation of BMP signaling is essential for correct dorsoventral
patterning of the amphibianmesoderm (Khokha et al., 2005; Reversade
and De Robertis, 2005) and signaling in Drosophila by the BMP or-
thologue, Dpp, is known to require HSPGs (Lin, 2004). One study has
shown that QSulf1 can release HSPG bound Noggin from the surface of
tissue culture cells, making the cells responsive to BMP treatment
(Viviano et al., 2004).We investigatedwhether XtSulf1 could affect BMP
signaling using Western blotting to detect endogenous phospho-
SMAD1 (pSMAD1) which is activated in response to BMP signaling.
Fig. 4A shows that pSMAD1 induced by BMP4 in animal cap ectodermal
explants is inhibited by the over-expression ofXtSulf1. The constitutivelyssion of XtSulf1 on BMP4 activity, while (J–P) show the effects of XtSulf1 knock-down on
jected with mRNA coding for BMP4 or the constitutively active BMP receptor Alk3. Over-
ffect on the pSMAD1 activation by Alk3. (B) A GST-BMP receptor fusion proteinwas used
associated with the BMP receptor. (C) XtSulf1 over-expression in stage 18 animal caps
hybridisation shows that the BMP target genes sizzled (D–F) and Msx1 (G–I) are down-
embryos, panels E and H have been injected unilaterally at the 2-cell stage with 2 ng of
ith a total of 4 ng of XtSulf1mRNA. (J) Western blotting to detect phospho-SMAD1/5/8 in
ted levels of pSMAD1; this effect is rescued by co-injecting mRNA coding for XtSulf1. In
d at the 2-cell stage with an AMO against XtSulf1 (L, N, P) have reduced levels of Otx2 (K
442 S.D. Freeman et al. / Developmental Biology 320 (2008) 436–445active BMP receptor Alk3 also activates pSMAD1, however this
activation is ligand independent (Hansen et al., 1997). The induction of
pSMAD1 by Alk3 is not inhibited by XtSulf1 over-expression indicating
that XtSulf1 acts on extracellular BMP signaling. Interestingly, this
ﬁnding that XtSulf1 can inhibit BMP signaling in isolated animal caps is
in contrast to the previous reports that suggest Sulf1 indirectly enhances
BMP responsiveness in cells by reducing cells' afﬁnity for Noggin
(Viviano et al., 2004). While the simplest interpretation of our data is
that XtSulf1 inhibits BMP signaling in a Noggin independent manner,
Noggin transcripts have been detected in the animal hemisphere at
blastula stages (Huang et al., 2007; Kuroda et al., 2004), therefore any
indirect effects of XtSulf1 on BMP inhibitors are not ruled out.
To address this, we looked more directly at the association of the
BMP receptor and ligand in the presence and absence of XtSulf1 using
GST pull-down (Fig. 4B). 2-cell embryos were injected into one
blastomere with mRNA coding for a BMP receptor-GST fusion protein,
with or without co-injection of XtSulf1 mRNA. The other blastomere
was injected with mRNA coding for HA-tagged BMP4. The association
of HA-BMP4 with the BMP-R-GST was detected by Western blotting
with an anti-HA antibody. The relative amount of BMP4 ligand pulled
down by the GST-BMP receptor was quantiﬁed using SynGene
software (Supplementary data). We ﬁnd that in the presence of
XtSulf1, 50% less BMP4 ligand is found in the protein sample pulled
down on BMP-R-GST beads, indicating that the presence of XtSulf1
directly impacts on and inhibits receptor–ligand interaction.
In keeping with a role for XtSulf1 in BMP inhibition, we have
observed that cultured animal cap explants over-expressing XtSulf1
sometimes form cement glands (not shown). To determine whether
any neural tissue is present we analysed the expression of NCAM in
animal caps using RNAase protection analysis (Fig. 4C).We found that a
low level of NCAM expression is detectable in animal cap explantsFig. 5. XtSulf1 inhibits FGF signaling in Xenopus embryos and disrupts somitogenesis. (A–G) sh
of XtSulf1 knock-down on FGF activity. (A)Western blotting shows the induction dpERK in sta
expressingXtSulf1.When theMAPKpathway is intracellularly activated bya drug inducible FG
the FGF target genesMyoD (B–D) and Xbra (E–G) are down-regulated in embryos over-expres
been injected unilaterally at the 2-cell stagewith 2 ng of XtSulf1mRNA, panels D and G have be
Western blotting to detect dpERK in X. tropicalis embryos at stage 14 in embryos where XtSu
injecting mRNA coding for XtSulf1. In situ hybridisation shows that the FGF regulated gene C
uninjected control, (J) unilaterally injected at the 2-cell stage with AMO3, (K) injected into
unilaterally injected with AMO3 and probed with MyoD. The uninjected side (L) shows norm
down (M) continues to express MyoD, but does not segment to form somites. Whole mount
embryos unilaterally injected with a control morpholino (N). In embryos unilaterally inject
horizontal lines). In situ hybridisation for bowline and thylacine panels Q–V shows an ant
expression in a stage 17 embryo unilaterally that was injected with a control morpholino at
injected with AMO3 at the 2-cell stage. (T) Thylacine expression in a stage 17 embryo unilate
expression in stage 17 embryos that were unilaterally injected with AMO3 at the 2-cell stage.over-expressing XtSulf1, while there is no expression of Xbra. This
suggests that there is some neural tissue and nomesoderm forming in
these explants, consistent with XtSulf1 acting to inhibit BMP signaling.
The very low levels of NCAMdetected is reasonable as neural induction
requires FGF signals aswell as the inhibition of BMP signaling (Delaune
et al., 2005) and XtSulf1 inhibits both these pathways (see below).
XtSulf1 acts in vivo to restrict BMP signaling during development
High levels of zygotic XtSulf1 expression are not detected until late
gastrula stages, and as such, it will not be involved in modulating BMP4
signaling during this time frame. However, we analysed the expression
of genes known to be regulated by BMP signaling, Szl (Marom et al.,
1999) andMsx1 (Suzuki et al.,1997), in the early gastrula to further assay
the effects of XtSulf1 on BMP4 activity.We found that over-expression of
XtSulf1 dramatically down-regulated the expression of Szl (Figs. 4D–F)
andMsx1 (Figs. 2G–I).
The over-expression data support a biological activity for XtSulf1 as
a BMP inhibitor. To determine whether the normal function of XtSulf1
is to restrict BMP activity we analysed XtSulf1 knock-down embryos at
stage 14, just after XtSulf1 expression would normally be activated.
Western blotting for phospho-SMAD1 shows there is more pSMAD1
present in embryos injected with either AMO targeted against XtSulf1
as compared to control embryos (Fig. 4J). This effect is rescued by co-
injection of XtSulf1 mRNA. The increased activity of the BMP4
signaling pathway in embryos lacking XtSulf1 strongly supports the
notion that XtSulf1 is an endogenous inhibitor of BMP4.
The effects of XtSulf1 knock-down on gene expression indicate that
Otx2 (Figs. 4K and L) and Pax6 (Figs. 4M–P) are down-regulated, as
seen in embryos over-expressing BMP4 under the control of Pax6
promoter in transgenic embryos (Hartley et al., 2001). These effectsow the effects of over-expression of XtSulf1 on FGF activity, while (H–V) show the effects
ge 10 animal caps treatedwith FGF4 protein from stage 8 is inhibited in animal caps over-
F receptor, XtSulf1 does not affect the induction of dpERK. In situ hybridisation shows that
sing XtSulf1. Panels B and E are uninjected stage 10 control embryos, panels C and F have
en injected into all blastomeres at the 4-cell stagewith a total of 4–8 ng of XtSulf1mRNA.
lf1 has been knocked down shows elevated levels of dpERK; this effect is rescued by co-
dx4 (I–K) is up-regulated in neurula embryos where XtSulf has been knocked down. (I)
both blastomeres at the 2-cell stage. Panels L and M show the two sides of an embryos
ally segmented somites (arrowheads), while the side where XtSulf1 has been knocked
immunostaining for dpERK (N–P) shows staining in the posterior mesoderm in stage 14
ed with AMO3 (O and P) dpERK increases and extends anteriorly (shift is indicated by
erior shift of the onset of somitogenesis where XtSulf1 is knocked down. (Q) Bowline
the 2-cell stage. (R and S) Bowline expression in stage 17 embryos that were unilaterally
rally that was injected with a control morpholino at the 2-cell stage. (U and V) Thylacine
Arrow heads in panels Q–V indicate the most posterior, newly determined somitomere.
443S.D. Freeman et al. / Developmental Biology 320 (2008) 436–445are consistent with XtSulf1 acting as an endogenous inhibitor modu-
lating BMP regulation of genes during post-gastrula stages.
XtSulf1 acts in vivo to restrict FGF signaling during somitogenesis
FGF signaling is crucial for mesoderm induction (Cornell and
Kimelman,1994), appropriate cell movements during gastrulation and
for the expression of a subset of mesodermal genes (Amaya et al.,
1991; Isaacs et al., 1994). QSulf1 has been shown to inhibit mesoderm
induction by FGF in ectodermal explants (Wang et al., 2004) and, as
expected, we ﬁnd that over-expressing XtSulf1 results in the down-
regulation of FGF induced diphospho-ERK (dpERK) as analysed using
Western blotting (Fig. 5A). Intracellular activation of the MAPK
pathway using a drug inducible FGF receptor (Pownall et al., 2003)
is not inhibited by XtSulf1, which is in keeping with XtSulf1 being
present and active extracellularly. Consistent with an ability to inhibit
FGF signaling, in situ hybridisation shows that the expression of the
FGF targets MyoD (Fisher et al., 2002; Standley et al., 2001) and Xbra
(Isaacs et al., 1994; Schulte-Merker and Smith, 1995), is inhibited in
embryos injected either unilaterally or bilaterally with XtSulf1 mRNA
(Figs. 5B–G).
To determine any endogenous role for XtSulf1 as an FGF inhibitor,
we analysed XtSulf1 knock-down embryos at stage 14, just after
XtSulf1 expression would normally be activated. Western blotting for
dpERK shows that there is more dpERK present in embryos injected
with either AMO targeted against XtSulf1 as compared to control
embryos (Fig. 5H). This effect is rescued by co-injection of XtSulf1
mRNA. The increased activity of the FGF signaling pathway in
embryos lacking XtSulf1 strongly supports the notion that XtSulf1 is
an endogenous inhibitor of FGF signals. This is further supported by
the effects of XtSulf1 knock-down on gene expression which show
up-regulation of Cdx4 (Figs. 5I–K) very similar to that seen in em-
bryos over-expressing FGF during and after gastrulation (Pownall et
al., 1996).
Analysis of XmyoD expression (Figs. 5L–M) in XtSulf1 knock-down
embryos reveals a lack of segmented paraxial mesoderm (Fig. 5M),
consistent with a role for XtSulf1 in modulating FGF signaling during
somitogenesis. Given the expression ofXtSulf1 in theparaxialmesoderm
(Fig. 1A) and the importance of restricting FGF signals during somite
segmentation (Dubrulle et al., 2001), we further analysed the effects of
XtSulf1 knock-down on this process. Figs. 5N–P show whole mount
immunostaining for endogenous dpERK. In control embryos at stage 14,
high levels of dpERK are detected in the posteriormesoderm (Fig. 5N). In
embryos unilaterally injected with an AMO to knock-down XtSulf1 on
one side of the embryo, dpERK levels extendmore anteriorly on the side
of the embryo lacking XtSulf1 (Figs. 5O–P).
To analyse the process of somitogenesis, we analysed the
expression of Bowline (Figs. 5Q–S) which is expressed in the anterior
pre-segmental plate mesoderm (PSM) and thought to be part of a
negative feedback loop to terminate the somite-forming process
(Hitachi et al., 2008). We also analysed the expression of Thylacine1
(Figs. 5T–V) which marks somitomeres I–III (Sparrow et al., 1998).
Somitomere III represents the determination front in the anterior PSM
where cells are allocated to somites (marked by arrowheads in Figs.
5Q–V). When embryos that have been unilaterally injected with an
AMO to knock-down XtSulf1 on one side of the embryo are analysed
by in situ hybridisation at stage 17, we ﬁnd that the expression of
Bowline (Figs. 5R–S) and Thylacine1 (Figs. 5U–V) are both shifted
anteriorly. This suggests that the determination front, which is set by a
threshold level of FGF signaling (Dubrulle et al., 2001), is delayed in
the absence of XtSulf1. Together with the anterior extension of dpERK
in the paraxial mesoderm of knock-down embryos, this data strongly
supports an in vivo role for XtSulf1 in restricting FGF signaling in the
PSM and provides an additional mechanism for the formation of a
morphogen gradient to regulate somitogenesis (Dubrulle and Pour-
quie, 2004; Nagano et al., 2006).Discussion
XtSulf1 and Wnt signaling
While there is a vast amount of biochemical and tissue culture
studies that describe the nature of the essential role for HSPGs in FGF
signaling (Ornitz, 2000), less detail is known about the requirement of
HSPGs for Wnt signaling. Genetic studies have established that HSPGs
are required for Wnt signaling: Drosophila glypican mutants such as
dally and other mutants (including ttv, sgl, and sﬂ) that lack HS are
defective in Wg signaling (Lin, 2004). There are also some clear
biochemical data showing that Wnt ligands bind heparin with great
afﬁnity, and that reducing 6-O-sulfation of the HS chains with QSulf1
results in the reduction ofWnt binding to heparin (Ai et al., 2003). Our
ﬁndings are that, in the context of the Xenopus embryo, XtSulf1 can
modify HS structure and alter signaling by Wnt-11. Injection of mRNA
coding for Wnt11 has very weak axes-inducing activity (Du et al.,
1995; Ku and Melton, 1993; Tao et al., 2005), however, when we co-
express XtSulf-1 and Wnt11 a high percent of embryos form
duplicated axes. The activation of some canonical Wnt signaling is
evident since we can detect Xnr3 and Chordin in the VMZ of embryos
co-injected with Wnt11 and XtSulf-1. Furthermore, the increased
amount of LRP6 associated with Wnt11 in the presence of XtSulf1
supports the notion that XtSulf1 can promote canonical Wnt signaling
by Wnt11.
XtSulf1 injected embryos also often fail to gastrulate properly,
consistent with the enhancement of the well documented activity of
Wnt11 in regulating convergent extension (Du et al., 1995; Kuhl, 2002;
Kuhl et al., 2001; Kuhl et al., 2000). The zebraﬁsh glypican mutant
knypek (Topczewski et al., 2001) has a convergent extension
phenotype similar to that of silberblick/wnt11 (Heisenberg et al.,
2000); this effect is additive when both these genes are defective and
it has been suggested that Kny might act to localise ligand to the cell
surface to promote Wnt signaling. However, Kny only seems to play a
role in convergent extension and not β-catenin stabilisation. In Xe-
nopus, expression of Wnt11 blocks convergent extension movements
in activin treated animal caps (Du et al., 1995) as does inhibition or
over-expression of glypican-4 or syndecan-4 (Munoz et al., 2006;
Ohkawara et al., 2003). We have found that over-expressing XtSulf-1
also inhibits elongation of activin treated caps (data not shown) and it
enhances the ability of Wnt11 to block convergent extension move-
ments in this assay. However, these results are not easy to interpret in
the context of Wnt signaling because blocking FGF signaling with a
dominant negative FGF receptor has this same effect (Cornell and
Kimelman, 1994) and given that XtSulf1 inhibits FGF signaling this
would mask any effects of Sulf1 on Wnt signaling in these assays.
XtSulf1: another BMP inhibitor
Amajor player in patterning the dorsoventral (DV) axis in embryos
is the regulation of BMP activity. In vertebrates, dorsally secreted BMP-
antagonists prevent ventrally expressed BMP ligands from signaling:
this creates a morphogen gradient of BMP activity across the DV axis.
The regulation of BMP signaling is extremely complex and the many
antagonists that include noggin, chordin, follistatin, cerberus, Xnr3,
sizzled and crossveinless are expressed either dorsally or ventrally in
the gastrula embryo (De Robertis and Kuroda, 2004). We present here
another mechanism to restrict BMP activity: the modiﬁcation of HSPG
structure by XtSulf1. Embryos lacking XtSulf1 show increased levels of
BMP activity, however, since XtSulf1 is not expressed zygotically until
late gastrula stages the effect of XtSulf1 knock-down is not ventralisa-
tion, rather these embryos resemble those over-expressing BMP4 after
gastrulation in transgenic embryos (Hartley et al., 2001).
We have shown that XtSulf1 blocks BMP4 induction of pSMAD1 in
animal explants and that the over-expression of XtSulf1 can inhibit the
ability of the BMP ligand to bind its receptor. These data point to a
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promoting BMP receptor–ligand interaction, similar to the models
that support speciﬁcity of the HSPG promotion of FGF signaling
(Schlessinger et al., 2000). Another means by which XtSulf1 could
inﬂuence BMP signaling is at the level of receptor–ligand endocytosis.
In Fig. 4B, there is somewhat less receptor, as well as signiﬁcantly less
ligand, present in the sample expressing XtSulf1, while the overall
amount of protein is not decreased as determined by Coomassie
staining. It is possible that the presence of XtSulf1 can modulate the
internalization and processing of the ligand receptor complex, as
HSPGs are thought to inﬂuence this process (Degnin et al., 2004).
While our data are in keeping with the direct inhibition of BMP
signaling at the level of receptor–ligand interaction, the possibility
that Sulf1 inﬂuences the activity of secreted BMP inhibitors cannot be
ruled out. Previous studies have shown that Noggin (Paine-Saunders
et al., 2002) and Chordin (Jasuja et al., 2004) bind HSPGs, and that
Noggin inhibition of BMP signaling is impaired in tissue culture cells
expressing QSulf1 (Viviano et al., 2004). The enhancement of BMP
signaling in these cells is due to the release of surface bound Noggin
due to QSulf1 remodelling HSPGs such that they no longer bind
Noggin. The authors of this work suggest an attractive model where
Sulf1 remodelling of HSPG structure in the context of an embryo could
allow efﬁcient diffusion of BMP inhibitors.
Modifying signals to create gradients
We further show that XtSulf1 is an important regulator of FGF
signaling during development. In the early embryo, FGF signaling is
crucial for mesoderm induction (Cornell and Kimelman, 1994),
appropriate cell movements and gene expression during gastrulation
(Amaya et al., 1991; Amaya et al., 1993; Isaacs et al., 1994) and for the
correct patterning of the anteroposterior axis (Pownall et al., 1996).
Zygotic XtSulf1 transcripts accumulate during late gastrula stages, in
regions overlapping those that are already expressing FGF8, FGF3 and
FGF4 (eFGF). Activation of XtSulf1 expression may provide a mechan-
ism to temporally and spatially attenuate FGF signaling subsequent to
mesoderm induction and during the patterning of the anteroposterior
axis as indicated by the up-regulation of the known direct target of
FGF signaling, cdx4 (Isaacs et al., 1998), in XtSulf1 knock-down
embryos.
At later stages, XtSulf1 continues to be expressed in the posterior
mesoderm just anterior to the FGF expressing cells. Inhibition of FGF
signaling by Shisa2 (Nagano et al., 2006), which is also expressed in
this region, has been shown to be essential for the formation of the
FGF gradient required for normal somitogenesis (Dubrulle and
Pourquie, 2004). The anterior extension of dpERK in the PSM and
the disruption of somitogenesis found in XtSulf1 knock-down
embryos are consistent with an additional, novel mechanism where
XtSulf1 regulates the dynamic activity of FGF necessary for segmenta-
tion. The ability of XtSulf1 to edit the structure of HSPGs causing cells
to become less responsive to signals (including FGF and BMP)
suggests that the presence of this enzyme can affect the shape or
slope of local morphogen gradients. In the retina, XtSulf1 is expressed
in the ciliary marginal zone (CMZ) where proliferative retinal stem
cells progressively become post-mitotic neurons. In Xenopus, the
ability of a retinal progenitor cell to respond to FGF signaling has been
shown to be important in determining its fate (McFarlane et al., 1998;
Patel and McFarlane, 2000; Zhang et al., 2003). It is possible that the
presence of XtSulf1 in the CMZ may inﬂuence the competence of
retinal stem cells to respond to different levels of FGF, thereby shaping
the local gradient of FGF activity to regulate stem cell determination
or timing of differentiation.
In frogs and mammals there is a related extracellular sulfatase,
Sulf2, and the X. tropicalis orthologue (Tegg037d24) has a distinct
expression pattern to that of Sulf1 and is largely restricted to anterior,
neural regions of the embryo (ECG and MEP, unpublished data). Theindividual knock-out of Sulf1 or Sulf2 results in normal, viable, fertile
mice; however, when both genes are targeted there is a signiﬁcant
reduction in body weight and a loss of post-natal viability (Holst et al.,
2007; Lamanna et al., 2006) that is at least in part due to the failure of
GDNF signaling during esophageal innervation in Sulf1/Sulf2 mutant
mice (Ai et al., 2007). The lack of a strong embryonic phenotype in
mice lacking Sulf1 and Sulf2 is in contrast to the XtSulf1 knock-down
in X. tropicalis reported here that fails to form a normal axis. This
difference could be due to the later expression of these genes in
amniotes (Holst et al., 2007; Zhao et al., 2006) as compared to Xenopus
where XtSulf1 has both maternal and early zygotic expression.
It has been shown that cancer cells positively and negatively
regulate the expression of HSulf1 which impacts signaling pathways
to promote tumour progression (Nawroth et al., 2007; Narita et al.,
2006). We have shown here that XtSulf1 can promote Wnt11 activity
and acts in vivo to restrict FGF and BMP signaling in the Xenopus
embryo, while its complex expression pattern points to an important
mechanism where the presence or absence of XtSulf1 will inﬂuence
local levels of developmental signaling.
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